About LCU   CME Meetings Meet The Professors Patterns of Care Patient Projects Other Tumor Types About Us
You are here: Home: LCU 1 | 2007: F Anthony Greco, MD: Select publications

SELECT PUBLICATIONS

Allerton JP et al. A phase II evaluation of the combination of paclitaxel protein-bound and carboplatin in the first-line treatment of advanced non-small cell lung cancer (NSCLC). Proc ASCO 2006; Abstract 7127.

Belani CP et al. Multicenter, randomized trial for stage IIIB or IV non-small-cell lung cancer using weekly paclitaxel and carboplatin followed by maintenance weekly paclitaxel or observation. J Clin Oncol 2003;21(15):2933-9. Abstract

Blum JL et al. Long term disease control in taxane-refractory metastatic breast cancer treated with nab paclitaxel. Proc ASCO 2004;Abstract 543.

Douillard J et al. ANITA: Phase III adjuvant vinorelbine (N) and cisplatin (P) versus observation (OBS) in completely resected (stage I-III) non-small-cell lung cancer (NSCLC) patients (pts): Final results after 70-month median follow-up. On behalf of the Adjuvant Navelbine International Trialist Association. ASCO 2005;Abstract 7013.

Gandara DR et al. Long-term survival in stage IIIb non-small cell lung cancer (NSCLC) treated with consolidation docetaxel following concurrent chemoradiotherapy (SWOG S9504). Proc ASCO 2005;Abstract 7059.

Gandara DR et al. Consolidation docetaxel after concurrent chemoradiotherapy in Stage IIIB non-small-cell lung cancer: Phase II Southwest Oncology Group Study S9504. J Clin Oncol 2003;21(10):2004-10. Abstract

Gradishar WJ. Albumin-bound paclitaxel: A next-generation taxane. Expert Opin Pharmacother 2006;7(8):1041-53. Abstract

Greco FA et al. Paclitaxel/carboplatin/etoposide versus paclitaxel/topotecan for extensive-stage small cell lung cancer: A Minnie Pearl Cancer Research Network randomized, prospective phase II trial. Oncologist 2005;10(9):728-33. Abstract

Greco FA et al. Carcinoma of unknown primary site: Sequential treatment with paclitaxel/carboplatin/etoposide and gemcitabine/irinotecan: A Minnie Pearl Cancer Research Network phase II trial. Oncologist 2004;9(6):644-52. Abstract

Herbst RS et al. TRIBUTE: A phase III trial of erlotinib hydrochloride (OSI-774) combined with carboplatin and paclitaxel chemotherapy in advanced non-small-cell lung cancer. J Clin Oncol 2005;23(25):5892-9. Abstract

Miller VA et al. Long survival of never smoking non-small cell lung cancer (NSCLC) patients (pts) treated with erlotinib HCl (OSI-774) and chemotherapy: Sub-group analysis of TRIBUTE. Presentation. ASCO 2004;Abstract 7061.

Strauss GM et al. Adjuvant chemotherapy in stage IB non-small cell lung cancer (NSCLC): Update on Cancer and Leukemia Group B (CALGB) Protocol 9633. Proc ASCO 2006;Abstract 7007.

Winton T et al. Vinorelbine plus cisplatin vs observation in resected non-small-cell lung cancer. N Engl J Med 2005;352(25):2589-97. Abstract



Table of Contents Top of Page

Table of Contents

Interviews

F Anthony Greco, MD
- Select publications

Chandra P Belani, MD
- Select publications

Ronald B Natale, MD
- Select publications

CME Information

Faculty Disclosures

Editor's Office


LCU Media Center
Download PDF
Listen to Audio Files
Read Previous Issues
Home Terms of Use and General Disclaimer | Privacy Policy
Copyright © 2007 Research To Practice. All Rights Reserved.
Contact Us